General Archive
![](https://www.lifearc.org/wp-content/uploads/2024/01/image-1.png)
-
News releases
LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa
Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.
-
News releases
Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
-
News releases
New UK-based research project brings together world-leading institutions to transform care for people living with dementia
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
-
News releases
LifeArc strengthens Board of Trustees with new appointments
Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc’s Board of Trustees as Non-Executive Directors.
-
News releases
New programme to move potential MND drugs into clinical trials faster
EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials
-
News releases
LifeArc and Sarcoma UK fund research to guide treatment decisions in rare cancer
£150,000 grant will fund a study of a biomarker test that could improve outcomes for patients with a rare sarcoma…
-
News releases
LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.
-
News releases
LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections
Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)
-
Articles & blogs
Translational research into children’s rare diseases enters 5th year of collaborative funding
Accelerating research that will have a significant impact on the treatment of children and young people
-
News releases
Dr Jason Slingsby joins LifeArc as Chief Business Officer
Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.
-
News releases
LifeArc launches £40m funding call to create Translational Rare Disease Centres
Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.
-
News releases
£3m fund to accelerate development of new CF therapies
Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.